NCT03760237
- Conditions
- Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +20 more
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
Clinical trial condition
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
NCT03760237
NCT02692248
NCT03989466
NCT06627725
NCT02294487
NCT00747123
NCT06624007
NCT03936465
NCT04637165